New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Semaglutide is a member of family of drugs called GLP-1 agonists, which work by mimicking the effect of a natural hormone that helps reduce appetite, hunger and food intake.
The trial was funded by semaglutide's maker, Novo Nordisk, and in findings published in November it found that the 2.4 milligram dose of the drug cut the odds of Another SELECT analysis looked at differences in outcomes based on patients' gender. It found that women appeared to gain more of a heart-health benefit from the drug compared to men, but that both sexes did see reductions in terms of heart-related events.get COVID, they were less likely to die from the disease if they had been taking semaglutide, the research showed.This time, researchers looked at data from the FLOW trial, published in May and also funded by Novo Nordisk.
The new subset analysis found that people in the FLOW trial who got semaglutide at the 1 mg dose had lower odds for new-onset heart failure or hospitalization for heart failure, compared to those getting the placebo injection.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic vs Wegovy: The Risks And Side Effects of Semaglutide DrugsThe Best in Science News and Amazing Breakthroughs
Read more »
7 Risks of Ozempic and Wegovy Overuse as Cases Spikestrong|Title/strong|: Writer strong|Location/strong|: Los Angeles strong|Education/strong|: BA in History, Politics, and Economics from Royal Holloway, University of London strong|Expertise/strong|: Health, Science, and Wellness strong|Experience/strong|: Ferozan has 20 years of experience writing and editing in the health, wellness,...
Read more »
People Are Overdosing on Semaglutide Drugs like Ozempic and WegovyDosing errors in the medication semaglutide, prescribed as Wegovy and Ozempic, can cause severe or prolonged gastrointestinal issues that require medical attention
Read more »
Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare SolvencyNewswire Editor is a Common Dreams staff position.
Read more »
Ozempic, Wegovy and Mounjaro: The Dark Side of Weight-Loss DrugsHow dropping pounds using slimming drugs like Ozempic made these women realize they had been victims of fatphobia for years
Read more »
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss programSesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and diabetes treatments amid…
Read more »